Objectives: To highlight areas where persons who undergo BRCA1/2 mutation testing may benefit from psychosocial or behavioral support and intervention.
Data sources: Published scientific literature, cal, and research experiences.
Conclusion: Key psychosocial areas that deserve attention by clinicians and researchers include: indeterminate or inconclusive test results, selection of risk management strategies in unaffected BRCA1/2 mutation carriers, and genetic testing in minority communities.
Implications for nursing practice: By addressing the psychosocial issues faced by patients undergoing genetic testing for cancer, nurses have the potential to maximize opportunities for prevention, early detection, and healthy coping.